09:05:16 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-06-25 Årsstämma 2025
2025-03-05 Bokslutskommuniké 2024
2024-11-27 Kvartalsrapport 2024-Q3
2024-09-25 Kvartalsrapport 2024-Q2
2024-06-27 X-dag ordinarie utdelning SOFTX 0.00 NOK
2024-06-26 Årsstämma 2024
2024-06-24 Kvartalsrapport 2024-Q1
2024-03-27 Extra Bolagsstämma 2024
2024-03-20 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-09-26 Kvartalsrapport 2023-Q2
2023-06-21 Årsstämma 2023
2023-06-21 Kvartalsrapport 2023-Q1
2023-03-30 X-dag ordinarie utdelning SOFTX 0.00 NOK
2023-02-17 Bokslutskommuniké 2022
2022-12-09 Extra Bolagsstämma 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-08-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-19 X-dag ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 Årsstämma 2022
2022-02-16 Bokslutskommuniké 2021
2021-12-29 Extra Bolagsstämma 2021
2021-11-17 Kvartalsrapport 2021-Q3
2021-09-08 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-14 X-dag ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-12-14 Kvartalsrapport 2020-Q3
2020-09-30 Kvartalsrapport 2020-Q2
2020-07-01 X-dag ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 Kvartalsrapport 2020-Q1
2020-06-30 Årsstämma 2020
2019-12-20 Extra Bolagsstämma 2019
2019-06-27 Årsstämma 2019
2019-06-03 X-dag ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 Split SOFTX 1:50

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo, Norge.
2023-05-23 13:33:58
Reference is made to the stock exchange announcements by the Company on 11 May,
27 March and 13 March 2023 regarding the Company's efforts to secure and
strengthen the Company's liquidity in the short and long term, and the Company's
work to explore solutions to financially strengthen the Company.
On 11 May 2023, the Company announced that it had secured interim financing
through a NOK 9 million funding from certain shareholders and investors. In the
first round of funding, which may be increased to an aggregate amount of NOK 16
million, the funds will be 20% as equity and 80% as a loan to the Company's
subsidiary Water Innovation AB (WIAB) (the "WIAB Loan"). The equity will be
contributed in a private placement of minimum NOK 1.8 million and maximum NOK
3.2 million new shares at a subscription price per share of NOK 8 per new share
(the "Private Placement"). The WIAB Loan, which will be in the aggregate of
minimum NOK 7.2 million and maximum 12.8 million, will mature on 31 January
2024, at which point the interest accrued on the loan shall be 25%. The WIAB
Loan may be converted to new shares in the Company at a subscription price of
NOK 8 per share at maturity of the loan (i.e. in January 2024), or at an earlier
capital raise in the Company, at the lenders discretion, provided, however, that
in the event of an advance conversion of the WIAB Loan, the interests accrued on
the individual lenders loan amount shall be reduced proportionally to reflect
the shorter period of interests accrued.
Further, the board of directors proposes that the Company issues minimum
2,700,000 and maximum 4,800,000 warrants (the "Warrants"), to be finally
determined when the final amount of funding in the first round has been fixed,
and no later than on the day before for general meeting. The number of Warrants
shall be calculated as follows: The aggregate amount of the WIAB Loan multiplied
by 3 and then divided by 8 (which is the offer price in the Private Placement.
The Warrants are to be allocated amongst the lenders, proportionally to the
respective amount of the WIAB Loan. Each Warrant will give the holder the right
to subscribe for and be allocated one new share in the Company at a subscription
price of NOK 8 per new share. 1/3 of the Warrants will expire on 31 January
2024, when Warrants can be exercised against conversion of debt, while the
remaining 2/3 of the Warrants will expire on the date falling five years after
issuance, i.e. on 29th of May 2028. The Warrants will not be transferrable.
Current shareholders who wish to participate in the WIAB Loan and the Private
Placement with a total investment amount of minimum NOK 250,000 can contact the
chairman of the Company. There can be no guarantee that shareholders are able or
allowed to participate.
The net proceeds from the WIAB Loan will be used by WIAB to secure the Company's
intellectual property and pay back a loan to the parent company (SoftOx
Solutions AS). The net proceeds from the Private Placement will be used for
general corporate purposes, including payment of some of the debt in the
Company. At current cost and activity levels of the Company, and assuming the
minimum capital raised (NOK 9 million) will give the Company a runway of
approximately 6 months, any further capital raised in this first round will
solely be used to partly pay down the Company's short-term debt, which is
currently approx. NOK 20 million.
As part of program for financial restructuring of the Company, the Company has
reduced the cost of running the Company from approx. NOK 8 million per month to
approx. NOK 1 million per month. As part of that program, the management and
members of the board have accepted to partly postpone payment of accrued and
future salaries, board remuneration and consulting fees till end of 1st quarter
2024 with an aggregate amount of maximum NOK 6 million. The board of directors
thus proposes to issue 2,250,000 warrants to be granted these employees and
board members, free of charge and otherwise on the same terms and conditions as
the Warrants. Provided, however that, 1/3 of the warrants granted must be
exercised before 31 March 2024 and will be conditional on the employment or
directorship not having been terminated at the time, while the remaining 2/3 of
the warrants may be exercised within 29th of May 2028 with no such condition.
Further, as also announced in the 11 May 2023 stock exchange announcement, the
Board of Directors intends to raise NOK 20 to 50 million in new equity by way of
a rights issue or other structures, to be determined by the board of directors
based on prevailing market conditions and terms deemed to be overall in the best
interest of the Company. The board of directors has thus proposed that it is
granted an authorisation to issue new shares.
The proposed resolutions regarding the Private Placement, issuances of warrants
and authorisation to the board of directors to issue shares are required in
order to secure the Company's funding need going forward. It will thus be
proposed that items 5 - 7 are voted over jointly at the general meeting.
The Private Placement entails a deviation of existing shareholders' preferential
rights to subscribe new shares in the Company. As further described in the stock
exchange announcement from the Company on 23 May 2023, the board has considered
the requirements for equal treatment of shareholders set out in the rules for
issuers admitted to trading on Euronext Growth Oslo, and has concluded that the
Private Placement is compliant with the equal treatment requirements to which
the Company is subject. This is inter alia based on the Company's severely
constrained liquidity situation, the Offer Price is at a premium compared to the
trading price of the share on the date preceding this notice, that the Company
has explored several financing solutions and concluded that the current proposal
is considered necessary in order to secure the short-term liquidity needs of the
Company. Further, a repair issue is deemed to require too much resources and
costs for the Company at this time, and the board of directors instead intends
to carry out a rights issue or similar capital raise involving a broader
shareholder base.

With respect to events following the last balance sheet date that are material
for the Company, reference is made to interim reports, stock exchange
announcements and information published by the Company through the Oslo Stock
Exchange's information system.

For further information, please contact:
CoB Geir Almås of SoftOx Solutions AS, or
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599 or (+47) 977 59 071